Tumor Lysate-Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy. [electronic resource]
Producer: 20200214Description: e1800837 p. digitalISSN:- 2192-2659
- Animals
- Cancer Vaccines -- immunology
- Cell Proliferation
- Combined Modality Therapy
- Dendritic Cells -- metabolism
- Female
- Immunotherapy
- Lipids -- chemistry
- Lymph Nodes -- pathology
- Melanoma, Experimental -- immunology
- Mice, Inbred C57BL
- Nanoparticles -- chemistry
- Peptides -- pharmacology
- Phosphates -- chemistry
- Spleen -- pathology
- T-Lymphocytes -- cytology
- Zinc Compounds -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.